Renasant Bank Pfizer Inc Transaction History

Renasant Bank

$134 Million
Q2 2025

A detailed history of Renasant Bank transactions in Pfizer Inc stock. As of the latest transaction made, Renasant Bank holds 41,897 shares of PFE stock, worth $1.04 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

41,897

Holding current value

$1.04 Million

% of portfolio

0.76%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$21.59 - $24.84 $904,556 - $1.04 Million	41,897 New	41,897 $1.02 Million
Q2 2023 Aug 01, 2023	SELL	$36.12 - $41.79 $33,880 - $39,199	-938 Reduced 13.89%	5,817 $213,000
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $24,264 - $31,588	616 Added 10.03%	6,755 $275,000
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $17,451 - $22,781	418 Added 7.31%	6,139 $314,000
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $50,630 - $61,806	-1,157 Reduced 16.82%	5,721 $250,000
Q2 2022 Aug 03, 2022	SELL	$46.53 - $55.17 $52,904 - $62,728	-1,137 Reduced 14.19%	6,878 $361,000
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $76,448 - $94,728	1,671 Added 26.34%	8,015 $415,000
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $5,082 - $7,533	-123 Reduced 1.9%	6,344 $375,000
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $194,640 - $250,032	-4,959 Reduced 43.4%	6,467 $278,000
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $47,616 - $53,941	1,326 Added 13.13%	11,426 $447,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $46,685 - $52,651	-1,394 Reduced 12.13%	10,100 $366,000
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $384,704 - $489,184	11,494 New	11,494 $423,000

Others Institutions Holding PFE

# of Institutions

3,294

Shares Held

3.66B

Call Options Held

96.1M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

News

Stay updated on Renasant Bank with notifications on news.

Account